< Back to search
Filter
1

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

for
Orthostatic; Hypotension, Neurogenic, Autonomic Failure,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 40 - 70+

Code: NCT04782830

Recruiting

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05192122

Phase1, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

Genetic Inclusion by Virtual Evaluation

for
Birth Defects, Multiple Congenital Anomaly,
Location: Edinburg TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 18

Code: NCT05318222

Recruiting

A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients

for
Multiple Myeloma
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT01314625

Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06623630

Phase1, Recruiting

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: St. John's, Moncton, Saint John, Quebec, Montreal,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06182774

Phase3, Recruiting

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

for
Multiple Myeloma in Relapse
Location: New York NY
Sponsor: Larysa Sanchez

Sex: All

Age: 70+

Code: NCT06827860

Phase2, Recruiting

UltrasouNd-guided Percutaneous Intercostal Nerve Cryoneurolysis for Analgesia Following Traumatic Rib Fracture

for
Rib Fractures, Rib Fracture Multiple,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18 - 70+

Code: NCT05865327

Recruiting

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06485076

Recruiting

A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients

for
Hemorrhagic Shock, Trauma, Wounds, Penetrating,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 12 - 45

Code: NCT00459160

Recruiting

Limited-duration Teclistamab

for
Myeloma Multiple
Location: New York NY, Philadelphia PA, Iowa City IA,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT05932680

Phase2, Recruiting

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

for
Multiple Myeloma, Smoldering, Multiple Myeloma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06055894

Recruiting

VitD3 Supplementation in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Augusta GA
Sponsor: Amany Keruakous, MD, MS.

Sex: All

Age: 18+

Code: NCT05846880

Early_phase1, Recruiting

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

for
Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT05976555

Phase1, Recruiting

Delayed Toxicities Post-CAR-T

for
Multiple Myeloma
Location: New York NY, San Francisco CA
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07665307

Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma (MM), Multiple Myeloma Refractory,
Location: Columbia MD, Nashville TN, Denver CO, Las Vegas NV,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07637578

Phase2, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase2, Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06768489

Phase1, Recruiting

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Baton Rouge LA, Tacoma WA, Los Angeles CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07609940

Recruiting